'Year follow' diaporamas de présentation

What Can We Glean from the Largest Organ in the Body?

Clinical Pearls in Dermatology Lisa H Scatena, M.D. F.A.A.D. Rocky Mountain Dermatology, Boulder Assistant Clinical Professor Dermatology & Internal Medicine University of Colorado, Denver 6 February 2009. What Can We Glean from the Largest Organ in the Body?.

1.7k views • 89 slides

What Can We Glean from the Largest Organ in the Body?

Clinical Pearls in Dermatology Lisa H Scatena, M.D. F.A.A.D. Rocky Mountain Dermatology, Boulder Assistant Clinical Professor Dermatology & Internal Medicine University of Colorado, Denver 6 February 2009. What Can We Glean from the Largest Organ in the Body?.

1.34k views • 89 slides

Mentalization-based Therapy: A summary of the evidence and new developments

Mentalization-based Therapy: A summary of the evidence and new developments. Dawn Bales, Helene Andrea, Ab Hesselink Psychotherapeutic Center de Viersprong, Viersprong Institute for Studies on Personality Disorders (VISPD) The Netherlands

3.05k views • 67 slides

Osteoporosis

Osteoporosis. PATHOGENESIS DIAGNOSIS TREATMENT. Robert D. Auerbach, M.D. FACOG Senior Vice President & Chief Medical Officer CooperSurgical, Inc. Associate Clinical Professor Yale University School of Medicine. Two Components of the Bone. Cortical Bone Dense and compact

1.6k views • 66 slides

Lethal Exposures: CO and CN (Carbon Monoxide and Cyanide)

1.25k views • 55 slides

Depression, Disability, and Death in Elders

936 views • 53 slides

Analysis of multiple informant/ multiple source data in Stata

Analysis of multiple informant/ multiple source data in Stata. Nicholas J. Horton Department of Mathematics Smith College, Northampton MA Garrett M. Fitzmaurice Harvard University nhorton at email.smith.edu http://www.biostat.harvard.edu/multinform. Acknowledgements.

763 views • 38 slides

The Swedish Shoulder Arthroplasty Register. 1999-2006

505 views • 33 slides

393 views • 27 slides

278 views • 27 slides

419 views • 27 slides

Testing an empirically-supported family based therapy (MDFT): USA vs. The Netherlands

Testing an empirically-supported family based therapy (MDFT): USA vs. The Netherlands. H. Liddle, C. Rowe Center for Treatment Research on Adolescent Drug Abuse University of Miami Miller School of Medicine H. Rigter Erasmus MC, Rotterdam V. Hendriks Parnassia Research Centre, The Hague.

668 views • 25 slides

TERIPARATIDE Lilly Research Laboratories

TERIPARATIDE Lilly Research Laboratories. Endocrinologic and Metabolic Drugs Advisory Committee Meeting Holiday Inn, Bethesda, Maryland July 27, 2001. Center for Drug Evaluation and Research. TERIPARATIDE Lilly Research Laboratories. Preclinical Safety Evaluation

668 views • 23 slides

285 views • 18 slides

Evaluating the risk factors associated with social care referral for babies of women who misuse alcohol or drugs

Evaluating the risk factors associated with social care referral for babies of women who misuse alcohol or drugs. Jessica Roy.

313 views • 18 slides

DIRECT REPAIR OF LUMBAR SPONDYLOLYSIS BY SEGMENTAL PEDICLE SCREW-INFRALAMINAR HOOK CONSTRUCT

DIRECT REPAIR OF LUMBAR SPONDYLOLYSIS BY SEGMENTAL PEDICLE SCREW-INFRALAMINAR HOOK CONSTRUCT. Cagatay OZTURK, MD Ahmet ALANAY, MD Meric ENERCAN, MD Selhan KARADERELER, MD Omer KARATOPRAK, MD Azmi HAMZAOGLU, MD Istanbul Spine Center Florence Nightingale Hospital Istanbul-TURKEY. PURPOSE.

1.26k views • 10 slides

Asymmetrical Corneal Topography in Map-Dot-Fingerprint Dystrophy Resembling Keratoconus

Asymmetrical Corneal Topography in Map-Dot-Fingerprint Dystrophy Resembling Keratoconus. Arie L. Marcovich 1,2 , Ori Mahler 1,2 , Ayala Pollack 1 , Samuel Levinger 2. 1 Department of Ophthalmology, Kaplan Medical Center Rehovot, Israel

1.07k views • 9 slides

TAXUS II and IV: two-year follow-up

TAXUS II and IV: two-year follow-up. TAXUS IV Trial. TAXUS II Trial. 1,326 patients with single de novo lesions Lesions 10-28 mm in length, 2.5-3.75 mm in diameter; Double blind, randomized trial. 536 patients with single de novo lesions Lesions < 12 mm in length, 3.0-3.5 mm in diameter;

244 views • 7 slides

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA 2002;288:2981-2997. ALLHAT. 42,418 patients with hypertension SBP > 140mmHg and/or DBP > 90 mmHg OR Took medication for hypertension and had at least one additional risk factor for CHD

263 views • 7 slides

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA 2002;288:2981-2997. ALLHAT. 42,418 patients with hypertension SBP > 140mmHg and/or DBP > 90 mmHg OR Took medication for hypertension and had at least one additional risk factor for CHD

407 views • 7 slides